The potential of this study to provide proof-of-concept (PoC) for the use of CT-996 in the treatment of obesity at Phase 1 is limited, given that Phase 1 studies are primarily designed to assess the safety and tolerability of a drug, rather than its efficacy in treating a particular condition

When red is a warning sign instead of a feature Red coloration is fine if it's: Clear (no cloudiness or particles) Uniform (no separation or layering) Disclosed on the label or in the pharmacy paperwork Consistent with your previous fills Red coloration is a warning sign if it's: Cloudy or murky Has visible particles Has separated into a clear top layer and red bottom layer Has a brown or rust tint suggesting oxidation Is dramatically different from previous fills, with no notification from the pharmacy The most common scenario where red is concerning: a vial sat in a hot car for several hours during shipping, the peptide partially degraded, and the resulting solution looks slightly different than expected

Research Highlight Published: GLP-1 receptor agonism Nature Aging volume 6 , pages 2728 (2026) Cite this article 729 Accesses 1 Citations 2 Altmetric Metrics details Regarding the recently announced failure of a GLP-1RA trial in clinical stage Alzheimers disease, we believe this highlights the need for a strategic shift, not an abandonment of the drug class in neurodegeneration, says Ho Ko, co-corresponding author of the study
No extra fees
What you might not be aware of, however, is